INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...
Please provide your email address to receive an email when new articles are posted on . “Authorized generic” versions of two of Eli Lilly's most popular insulins ...
Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...
INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by ...
Please provide your email address to receive an email when new articles are posted on . Lilly announced Tuesday that it will offer “authorized generic” versions ...
Eli Lilly is adding two more cost-saving options to its suite of solutions for people who use Lilly insulin by introducing lower-priced versions of Humalog Mix75/25 KwikPen and Humalog Junior KwikPen.
Zepbound KwikPen is the newly launched, multi-dose delivery option of Eli Lilly's weight-management medication. Patients filling GLP-1 prescriptions at Kroger Family of Pharmacies have access to a ...
INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units ...
FDA authorization now permits a 4-dose KwikPen presentation, consolidating one month of tirzepatide therapy into a single device for chronic weight management. LillyDirect self-pay pricing starts at ...
Today, Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, tirzepatide (Zepbound). The device gives patients an additional, potentially more convenient ...
Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results